Tuborg Havnevej 15, st.
Ground Floor
Hellerup 2900
Denmark
45 45 29 00 00
https://bioporto.com
Settore/i:
Settore:
Impiegati a tempo pieno: 29
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Prof. Lars Otto Uttenthal | Chief Scientific Officer | N/D | N/D | N/D |
Ms. Gry Husby Larsen | Executive VP & Chief Legal Officer | N/D | N/D | N/D |
Ms. Jennifer Zonderman | VP of Global Marketing & US Commercialization | N/D | N/D | N/D |
Mr. Nis Kruse | Executive VP of Strategic Partnerships and GM of EMEA & APAC | N/D | N/D | N/D |
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
L'ISS Governance QualityScore di BioPorto A/S al 1 maggio 2024 è 3. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 1; diritti degli azionisti: 1; retribuzione: 8.